Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Abstract Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). Objectives The study sought to compare the long-term outcomes of initial AVR versus conservative strategies...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 66; no. 25; pp. 2827 - 2838
Main Authors Taniguchi, Tomohiko, MD, Morimoto, Takeshi, MD, MPH, Shiomi, Hiroki, MD, Ando, Kenji, MD, Kanamori, Norio, MD, Murata, Koichiro, MD, Kitai, Takeshi, MD, Kawase, Yuichi, MD, Izumi, Chisato, MD, Miyake, Makoto, MD, Mitsuoka, Hirokazu, MD, Kato, Masashi, MD, Hirano, Yutaka, MD, Matsuda, Shintaro, MD, Nagao, Kazuya, MD, Inada, Tsukasa, MD, Murakami, Tomoyuki, MD, Takeuchi, Yasuyo, MD, Yamane, Keiichiro, MD, Toyofuku, Mamoru, MD, Ishii, Mitsuru, MD, Minamino-Muta, Eri, MD, Kato, Takao, MD, Inoko, Moriaki, MD, Ikeda, Tomoyuki, MD, Komasa, Akihiro, MD, Ishii, Katsuhisa, MD, Hotta, Kozo, MD, Higashitani, Nobuya, MD, Kato, Yoshihiro, MD, Inuzuka, Yasutaka, MD, Maeda, Chiyo, MD, Jinnai, Toshikazu, MD, Morikami, Yuko, MD, Sakata, Ryuzo, MD, Kimura, Takeshi, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 29.12.2015
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). Objectives The study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS. Methods We used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm2 ) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score–matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report. Results Baseline characteristics of the propensity score–matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively). Conclusions The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140 )
AbstractList Abstract Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). Objectives The study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS. Methods We used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm2 ) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score–matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report. Results Baseline characteristics of the propensity score–matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively). Conclusions The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140 )
BACKGROUNDCurrent guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS).OBJECTIVESThe study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS.METHODSWe used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm(2)) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score-matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report.RESULTSBaseline characteristics of the propensity score-matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively).CONCLUSIONSThe long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140).
Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). The study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS. We used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm(2)) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score-matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report. Baseline characteristics of the propensity score-matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively). The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140).
Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). The study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS. We used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm2) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score–matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report. Baseline characteristics of the propensity score–matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively). The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140)
Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). Objectives The study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS. Methods We used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm2) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score-matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report. Results Baseline characteristics of the propensity score-matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively). Conclusions The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry;UMIN000012140)
Author Kitai, Takeshi, MD
Komasa, Akihiro, MD
Yamane, Keiichiro, MD
Taniguchi, Tomohiko, MD
Ishii, Katsuhisa, MD
Ishii, Mitsuru, MD
Kimura, Takeshi, MD
Miyake, Makoto, MD
Hirano, Yutaka, MD
Inuzuka, Yasutaka, MD
Izumi, Chisato, MD
Inoko, Moriaki, MD
Higashitani, Nobuya, MD
Sakata, Ryuzo, MD
Kato, Takao, MD
Morimoto, Takeshi, MD, MPH
Shiomi, Hiroki, MD
Ikeda, Tomoyuki, MD
Mitsuoka, Hirokazu, MD
Kawase, Yuichi, MD
Hotta, Kozo, MD
Murakami, Tomoyuki, MD
Jinnai, Toshikazu, MD
Kato, Yoshihiro, MD
Ando, Kenji, MD
Kanamori, Norio, MD
Takeuchi, Yasuyo, MD
Morikami, Yuko, MD
Minamino-Muta, Eri, MD
Toyofuku, Mamoru, MD
Matsuda, Shintaro, MD
Murata, Koichiro, MD
Maeda, Chiyo, MD
Nagao, Kazuya, MD
Inada, Tsukasa, MD
Kato, Masashi, MD
Author_xml – sequence: 1
  fullname: Taniguchi, Tomohiko, MD
– sequence: 2
  fullname: Morimoto, Takeshi, MD, MPH
– sequence: 3
  fullname: Shiomi, Hiroki, MD
– sequence: 4
  fullname: Ando, Kenji, MD
– sequence: 5
  fullname: Kanamori, Norio, MD
– sequence: 6
  fullname: Murata, Koichiro, MD
– sequence: 7
  fullname: Kitai, Takeshi, MD
– sequence: 8
  fullname: Kawase, Yuichi, MD
– sequence: 9
  fullname: Izumi, Chisato, MD
– sequence: 10
  fullname: Miyake, Makoto, MD
– sequence: 11
  fullname: Mitsuoka, Hirokazu, MD
– sequence: 12
  fullname: Kato, Masashi, MD
– sequence: 13
  fullname: Hirano, Yutaka, MD
– sequence: 14
  fullname: Matsuda, Shintaro, MD
– sequence: 15
  fullname: Nagao, Kazuya, MD
– sequence: 16
  fullname: Inada, Tsukasa, MD
– sequence: 17
  fullname: Murakami, Tomoyuki, MD
– sequence: 18
  fullname: Takeuchi, Yasuyo, MD
– sequence: 19
  fullname: Yamane, Keiichiro, MD
– sequence: 20
  fullname: Toyofuku, Mamoru, MD
– sequence: 21
  fullname: Ishii, Mitsuru, MD
– sequence: 22
  fullname: Minamino-Muta, Eri, MD
– sequence: 23
  fullname: Kato, Takao, MD
– sequence: 24
  fullname: Inoko, Moriaki, MD
– sequence: 25
  fullname: Ikeda, Tomoyuki, MD
– sequence: 26
  fullname: Komasa, Akihiro, MD
– sequence: 27
  fullname: Ishii, Katsuhisa, MD
– sequence: 28
  fullname: Hotta, Kozo, MD
– sequence: 29
  fullname: Higashitani, Nobuya, MD
– sequence: 30
  fullname: Kato, Yoshihiro, MD
– sequence: 31
  fullname: Inuzuka, Yasutaka, MD
– sequence: 32
  fullname: Maeda, Chiyo, MD
– sequence: 33
  fullname: Jinnai, Toshikazu, MD
– sequence: 34
  fullname: Morikami, Yuko, MD
– sequence: 35
  fullname: Sakata, Ryuzo, MD
– sequence: 36
  fullname: Kimura, Takeshi, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26477634$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1r3DAQhkVJaTZp_0APxdBLL96ObOvDUArL0qSBQAvbj6Ow5XEq15a2kryw_75yNm0hh-oi6eWZYWbeuSBn1lkk5CWFNQXK3w7rodF6XQBlSVgD0CdkRRmTeclqcUZWIEqWU6jFObkIYQAALmn9jJwXvBKCl9WKdDfWRNOM2W72d0anxzf0YQ7Z1tmA_tBEc8BsF30T8c5gyIzNPicRbQzZdxN_ZJtwnPbRTUnU2Q4P6DHbOH__i2hdMOE5edo3Y8AXD_cl-Xr14cv2Y3776fpmu7nNNStlzGVdc6lFOghU8r6uk1LoFlpA7FvGsectpT1LbQFo2WkqChCs6SrEoujKS_LmlHfv3a8ZQ1STCRrHsbHo5qCoYCWALCqa0NeP0MHN3qbq7qmqklwsVHGitHcheOzV3pup8UdFQS0eqEEtHqjFg0VLHqSgVw-p53bC7m_In6En4N0JwDSLg0Gvgk4D1dgZjzqqzpn_53__KFyPxi7e_cQjhn99qFAoULtlC5YloAy4kHVZ_gYltK48
CitedBy_id crossref_primary_10_1038_s41598_018_28162_x
crossref_primary_10_1536_ihj_17_320
crossref_primary_10_1136_bmjopen_2017_016489
crossref_primary_10_1161_CIRCINTERVENTIONS_116_004796
crossref_primary_10_1016_j_cpcardiol_2022_101477
crossref_primary_10_1253_circj_CJ_19_0247
crossref_primary_10_3346_jkms_2021_36_e47
crossref_primary_10_1007_s10554_024_03160_5
crossref_primary_10_3390_jcm11113090
crossref_primary_10_1016_j_amjcard_2024_02_034
crossref_primary_10_1371_journal_pone_0296055
crossref_primary_10_1016_j_jacc_2017_03_023
crossref_primary_10_1038_s41598_017_15316_6
crossref_primary_10_1161_JAHA_117_005735
crossref_primary_10_1177_1753944719826420
crossref_primary_10_1161_JAHA_117_005850
crossref_primary_10_1002_joa3_12502
crossref_primary_10_1093_ehjci_jeaa295
crossref_primary_10_1016_j_jcmg_2018_09_020
crossref_primary_10_3390_jcdd8040035
crossref_primary_10_1007_s12928_023_00942_x
crossref_primary_10_1038_s41598_018_36066_z
crossref_primary_10_1016_j_jacc_2016_02_057
crossref_primary_10_3389_fcvm_2020_608158
crossref_primary_10_1016_j_jtcvs_2021_04_002
crossref_primary_10_1253_circj_CJ_21_1062
crossref_primary_10_1016_j_jacc_2015_11_013
crossref_primary_10_1097_CRD_0000000000000560
crossref_primary_10_1161_CIRCULATIONAHA_122_060125
crossref_primary_10_2217_bmm_2017_0083
crossref_primary_10_1016_j_jtcvs_2020_07_046
crossref_primary_10_1177_1089253220969576
crossref_primary_10_1253_circj_CJ_20_0135
crossref_primary_10_1161_JAHA_120_020490
crossref_primary_10_1016_j_amjcard_2016_04_044
crossref_primary_10_1080_24748706_2018_1479078
crossref_primary_10_1016_j_ihj_2016_05_006
crossref_primary_10_1136_neurintsurg_2018_014627
crossref_primary_10_1001_jamacardio_2018_2288
crossref_primary_10_1016_j_jacc_2019_04_065
crossref_primary_10_1007_s12928_020_00658_2
crossref_primary_10_1161_CIRCIMAGING_117_007084
crossref_primary_10_3904_kjim_2018_015
crossref_primary_10_1136_heartjnl_2019_316493
crossref_primary_10_1161_JAHA_120_020252
crossref_primary_10_1136_heartjnl_2022_321411
crossref_primary_10_4070_kcj_2018_0308
crossref_primary_10_1007_s00595_016_1458_6
crossref_primary_10_1253_circj_CJ_16_1244
crossref_primary_10_2459_JCM_0000000000000455
crossref_primary_10_1016_j_jcmg_2018_10_011
crossref_primary_10_1016_j_jacc_2020_11_035
crossref_primary_10_1016_j_rec_2019_11_006
crossref_primary_10_1007_s11936_017_0533_7
crossref_primary_10_1016_j_amjcard_2020_10_065
crossref_primary_10_1001_jamacardio_2018_3152
crossref_primary_10_1253_circj_CJ_19_0951
crossref_primary_10_1056_NEJMoa1912846
crossref_primary_10_1016_j_cjca_2023_11_029
crossref_primary_10_3389_fcvm_2021_660797
crossref_primary_10_1016_j_recesp_2019_11_015
crossref_primary_10_1016_j_jacc_2018_09_049
crossref_primary_10_1001_jamacardio_2020_2497
crossref_primary_10_1016_j_carrev_2022_03_001
crossref_primary_10_1253_circj_CJ_20_0130
crossref_primary_10_1016_j_jacc_2016_01_066
crossref_primary_10_1016_j_jacc_2016_01_065
crossref_primary_10_1371_journal_pone_0222979
crossref_primary_10_1093_ehjci_jeac046
crossref_primary_10_1253_circj_CJ_21_0200
crossref_primary_10_1016_j_jcin_2023_07_007
crossref_primary_10_1016_j_jcmg_2017_10_003
crossref_primary_10_1093_eurheartj_ehad355
crossref_primary_10_1016_j_ijcha_2022_101125
crossref_primary_10_1016_j_ijcard_2016_10_070
crossref_primary_10_17116_kardio202316031246
crossref_primary_10_1080_24748706_2017_1329959
crossref_primary_10_4997_JRCPE_2017_217
crossref_primary_10_1007_s12055_022_01382_7
crossref_primary_10_1161_JAHA_121_021126
crossref_primary_10_1253_circj_CJ_20_0681
crossref_primary_10_1016_j_athoracsur_2023_08_015
crossref_primary_10_1016_j_jacc_2020_11_018
crossref_primary_10_1016_j_bja_2019_10_023
crossref_primary_10_1161_JAHA_118_009195
crossref_primary_10_1161_HYPERTENSIONAHA_119_13797
crossref_primary_10_1016_j_jtcvs_2020_08_047
crossref_primary_10_1016_j_repc_2016_01_001
crossref_primary_10_1161_JAHA_124_035078
crossref_primary_10_1016_j_tcm_2020_10_002
crossref_primary_10_1016_j_amjcard_2021_03_046
crossref_primary_10_1161_CIRCULATIONAHA_121_058598
crossref_primary_10_1016_j_athoracsur_2019_01_031
crossref_primary_10_1161_JAHA_117_005524
crossref_primary_10_3389_fcvm_2020_621149
crossref_primary_10_1136_heartjnl_2022_321204
crossref_primary_10_1016_j_jacc_2016_01_068
crossref_primary_10_1016_j_jacc_2016_01_067
crossref_primary_10_1016_j_amjcard_2019_01_035
crossref_primary_10_1136_heartjnl_2016_309830
crossref_primary_10_1080_14779072_2022_2137491
crossref_primary_10_1016_j_ahjo_2022_100197
crossref_primary_10_1016_j_ccl_2019_09_003
crossref_primary_10_1007_s12574_020_00490_w
crossref_primary_10_1136_heartjnl_2015_309071
crossref_primary_10_1016_j_jcin_2019_09_015
crossref_primary_10_1136_heartjnl_2020_317160
crossref_primary_10_4070_kcj_2019_0044
crossref_primary_10_1016_j_jacc_2015_12_003
crossref_primary_10_1136_heartjnl_2017_311506
crossref_primary_10_1093_ehjqcco_qcy010
crossref_primary_10_1177_2632463619899567
crossref_primary_10_1186_s12933_023_02009_w
crossref_primary_10_1136_heartjnl_2020_318256
crossref_primary_10_1016_j_rccar_2017_09_001
crossref_primary_10_1016_j_ahj_2016_02_001
crossref_primary_10_1016_j_rccar_2017_09_002
crossref_primary_10_1007_s00059_017_4584_z
crossref_primary_10_1016_j_ijcard_2024_132183
crossref_primary_10_1161_CIRCIMAGING_117_006760
crossref_primary_10_1016_j_cpcardiol_2017_12_001
crossref_primary_10_1016_j_ahj_2023_11_019
crossref_primary_10_1016_j_jcmg_2016_06_009
crossref_primary_10_1371_journal_pone_0249610
crossref_primary_10_1007_s12265_016_9695_z
crossref_primary_10_1161_CIRCRESAHA_123_321760
crossref_primary_10_1253_circj_CJ_18_0416
crossref_primary_10_1111_jocs_14238
crossref_primary_10_1177_2632463620972215
crossref_primary_10_1038_s41569_019_0254_6
crossref_primary_10_1016_j_cpcardiol_2024_102725
crossref_primary_10_1016_j_repce_2016_03_002
crossref_primary_10_1007_s10143_023_02026_z
crossref_primary_10_1007_s11936_023_01020_4
crossref_primary_10_1136_openhrt_2023_002511
crossref_primary_10_2459_JCM_0000000000001110
crossref_primary_10_1093_ehjcvp_pvaa008
crossref_primary_10_1016_j_carrev_2020_01_025
crossref_primary_10_1253_circj_CJ_16_0333
crossref_primary_10_1016_j_jacc_2019_08_004
crossref_primary_10_1093_eurheartj_ehy244
crossref_primary_10_1136_heartjnl_2016_311022
crossref_primary_10_1016_j_hjc_2021_01_005
crossref_primary_10_1161_JAHA_117_008397
crossref_primary_10_1016_j_shj_2023_100201
crossref_primary_10_1161_CIRCULATIONAHA_116_025457
crossref_primary_10_1016_j_ijcard_2016_11_092
crossref_primary_10_1161_JAHA_115_003146
crossref_primary_10_1093_eurheartj_ehac803
crossref_primary_10_1161_CIR_0000000000000923
crossref_primary_10_1161_CIRCULATIONAHA_117_032839
crossref_primary_10_1161_JAHA_118_010198
crossref_primary_10_1016_j_mayocp_2018_01_020
crossref_primary_10_1016_j_cjca_2021_05_001
crossref_primary_10_1155_2021_3973924
crossref_primary_10_3390_jcm9092694
crossref_primary_10_1007_s10143_020_01259_6
crossref_primary_10_1016_j_acvd_2020_07_002
crossref_primary_10_1016_j_echo_2017_01_003
crossref_primary_10_1016_j_cjca_2023_09_025
crossref_primary_10_1016_j_jacadv_2024_100830
crossref_primary_10_1016_j_athoracsur_2017_02_039
crossref_primary_10_1253_circj_CJ_19_0431
crossref_primary_10_1136_heartjnl_2016_310399
crossref_primary_10_2459_JCM_0000000000000971
crossref_primary_10_1161_CIR_0000000000000932
crossref_primary_10_1161_CIRCHEARTFAILURE_121_009253
crossref_primary_10_1016_j_jtcvs_2020_06_078
crossref_primary_10_1111_echo_15662
crossref_primary_10_1093_ehjci_jey105
crossref_primary_10_1161_JAHA_118_008796
crossref_primary_10_1161_CIRCIMAGING_117_007131
crossref_primary_10_7759_cureus_16056
crossref_primary_10_1016_j_echo_2021_05_017
crossref_primary_10_1136_heartjnl_2019_315672
crossref_primary_10_1177_1479164118820657
crossref_primary_10_1016_j_jcin_2017_08_036
crossref_primary_10_1080_00015385_2022_2130444
crossref_primary_10_1016_j_jacc_2015_10_029
crossref_primary_10_1007_s11886_018_1072_x
crossref_primary_10_1007_s12265_021_10138_4
crossref_primary_10_1093_eurheartj_ehaa485
crossref_primary_10_1136_heartjnl_2017_312304
crossref_primary_10_1161_CIRCULATIONAHA_121_058505
crossref_primary_10_3390_ijms22126212
crossref_primary_10_4103_heartviews_heartviews_37_22
crossref_primary_10_1093_ehjqcco_qcab041
crossref_primary_10_1016_j_echo_2017_10_022
crossref_primary_10_1161_CIRCOUTCOMES_116_003287
crossref_primary_10_1016_j_jacc_2015_10_030
crossref_primary_10_1161_JAHA_116_004961
crossref_primary_10_1136_openhrt_2022_001982
crossref_primary_10_1016_j_ahj_2024_05_013
crossref_primary_10_1253_circj_CJ_20_0026
crossref_primary_10_1093_ehjqcco_qcz044
crossref_primary_10_1253_circj_CJ_21_0054
crossref_primary_10_4330_wjc_v9_i6_481
crossref_primary_10_1136_bmjopen_2024_086587
crossref_primary_10_1016_j_jacc_2016_02_021
crossref_primary_10_1016_j_ijcard_2017_09_183
crossref_primary_10_1016_j_jcmg_2019_01_036
crossref_primary_10_1080_00015385_2021_1939513
crossref_primary_10_3389_fcvm_2022_844876
crossref_primary_10_3390_jcm13123495
crossref_primary_10_1161_CIRCULATIONAHA_121_057639
crossref_primary_10_4103_2321_449X_183532
crossref_primary_10_2459_JCM_0000000000001338
crossref_primary_10_1080_24748706_2019_1652946
crossref_primary_10_1016_j_vhri_2019_07_013
crossref_primary_10_1016_j_jjcc_2022_08_006
crossref_primary_10_1016_j_amjcard_2021_12_027
crossref_primary_10_1016_j_amjcard_2020_10_013
crossref_primary_10_1007_s00059_021_05057_8
crossref_primary_10_1253_circj_CJ_17_0610
crossref_primary_10_1016_j_athoracsur_2023_01_028
crossref_primary_10_1007_s00380_021_01842_x
crossref_primary_10_1253_circj_CJ_16_0998
crossref_primary_10_1136_heartjnl_2018_313269
crossref_primary_10_1136_heartjnl_2020_317323
crossref_primary_10_1007_s11936_020_00837_7
crossref_primary_10_1016_j_tcm_2017_01_004
crossref_primary_10_1016_j_jcin_2017_10_011
crossref_primary_10_1093_ejcts_ezx362
crossref_primary_10_1016_j_jaccas_2019_08_012
crossref_primary_10_1016_j_jscai_2022_100383
crossref_primary_10_1016_j_shj_2022_100089
crossref_primary_10_1136_heartjnl_2022_320897
crossref_primary_10_1016_j_amjcard_2016_07_042
crossref_primary_10_1002_ehf2_13270
Cites_doi 10.1016/j.athoracsur.2006.07.043
10.1016/j.jacc.2012.09.001
10.1093/eurheartj/ehq076
10.1161/CIRCULATIONAHA.104.495903
10.1056/NEJMoa1008232
10.1016/0735-1097(90)90234-G
10.1016/j.jacc.2010.12.005
10.1161/CIRCULATIONAHA.109.909903
10.1016/j.jacc.2014.02.536
10.1161/01.CIR.0000126825.50903.18
10.1093/eurheartj/ehs109
10.1016/j.jtcvs.2007.08.058
10.1161/CIRCULATIONAHA.112.091371
10.1161/01.CIR.95.9.2262
10.1016/j.jtcvs.2008.08.015
10.1161/CIRCULATIONAHA.114.012906
10.1002/sim.3697
10.1161/CIRCULATIONAHA.109.894170
10.1016/j.echo.2008.11.029
10.1056/NEJM200008313430903
10.1056/NEJMoa1103510
ContentType Journal Article
Copyright American College of Cardiology Foundation
2015 American College of Cardiology Foundation
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Dec 29, 2015
Copyright_xml – notice: American College of Cardiology Foundation
– notice: 2015 American College of Cardiology Foundation
– notice: Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Dec 29, 2015
CorporateAuthor CURRENT AS Registry Investigators
CorporateAuthor_xml – name: CURRENT AS Registry Investigators
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.jacc.2015.10.001
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 2838
ExternalDocumentID 3912555721
10_1016_j_jacc_2015_10_001
26477634
S0735109715067893
1_s2_0_S0735109715067893
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
0SF
18M
1B1
1CY
1P~
1~.
1~5
29L
2WC
3O-
3V.
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
6PF
7-5
71M
7RV
8P~
AABNK
AABVL
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AAKUH
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAXUO
AAYOK
ABBQC
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABVKL
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ADBBV
ADEZE
ADMUD
ADVLN
AEFWE
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFETI
AFFNX
AFRAH
AFRHN
AFTJW
AGHFR
AGYEJ
AHMBA
AITUG
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLXMC
BPHCQ
CS3
DIK
DU5
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HX~
HZ~
IHE
IXB
J1W
J5H
K-O
KQ8
L7B
MO0
N4W
N9A
NCXOZ
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
QTD
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
T5K
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
X7M
XPP
YYM
YYP
YZZ
Z5R
ZGI
ZXP
AAIAV
EFLBG
LCYCR
NAHTW
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
7T5
7TK
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c538t-89968c7777e0186f998992cb0b0eefb56ef6b11f573500c8dc172075ad4ee22d3
IEDL.DBID IXB
ISSN 0735-1097
IngestDate Tue Dec 03 22:39:38 EST 2024
Thu Oct 10 22:51:27 EDT 2024
Fri Dec 06 03:01:25 EST 2024
Tue Oct 15 23:55:55 EDT 2024
Fri Feb 23 02:33:07 EST 2024
Tue Oct 15 22:52:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 25
Keywords registry
heart failure
peak aortic jet velocity
aortic valve replacement
LVEF
IQR
interquartile range
AVA
propensity-matched
left ventricular ejection fraction
pressure gradient
AS
aortic stenosis
STS
V max
PG
Society of Thoracic Surgeons
risk
aortic valve area
AVR
watchful waiting
HF
Vmax
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c538t-89968c7777e0186f998992cb0b0eefb56ef6b11f573500c8dc172075ad4ee22d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0735109715067893
PMID 26477634
PQID 1753448671
PQPubID 2031078
PageCount 12
ParticipantIDs proquest_miscellaneous_1753008241
proquest_journals_1753448671
crossref_primary_10_1016_j_jacc_2015_10_001
pubmed_primary_26477634
elsevier_sciencedirect_doi_10_1016_j_jacc_2015_10_001
elsevier_clinicalkeyesjournals_1_s2_0_S0735109715067893
PublicationCentury 2000
PublicationDate 2015-12-29
PublicationDateYYYYMMDD 2015-12-29
PublicationDate_xml – month: 12
  year: 2015
  text: 2015-12-29
  day: 29
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2015
Publisher Elsevier Inc
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
References Pellikka, Nishimura, Bailey, Tajik (bib7) 1990; 15
Otto, Burwash, Legget (bib1) 1997; 95
Brown, O'Brien, Wu, Sikora, Griffith, Gammie (bib4) 2009; 137
Smith, Leon, Mack (bib12) 2011; 364
Pai, Kapoor, Bansal, Varadarajan (bib13) 2006; 82
Martinsson, Li, Andersson, Nilsson, Smith, Sundquist (bib10) 2015; 131
Baumgartner, Hung, Bermejo (bib14) 2009; 22
Kappetein, Head, Genereux (bib16) 2012; 60
Nishimura, Otto, Bonow (bib6) 2014; 63
Brennan, Edwards, Zhao, O'Brien, Douglas, Peterson (bib5) 2012; 126
Austin (bib17) 2009; 28
Leon, Piazza, Nikolsky (bib15) 2011; 57
Bergler-Klein, Klaar, Heger (bib20) 2004; 109
Marechaux, Hachicha, Bellouin (bib19) 2010; 31
Rosenhek, Binder, Porenta (bib2) 2000; 343
Vahanian, Alfieri, Andreotti (bib18) 2012; 33
Rosenhek, Zilberszac, Schemper (bib9) 2010; 121
Leon, Smith, Mack (bib11) 2010; 363
Brown, Pellikka, Schaff (bib21) 2008; 135
Kang, Park, Rim (bib8) 2010; 121
Pellikka, Sarano, Nishimura (bib3) 2005; 111
27102517 - J Am Coll Cardiol. 2016 Apr 26;67(16):1971-2
26718671 - J Am Coll Cardiol. 2015 Dec 29;66(25):2842-3
27102515 - J Am Coll Cardiol. 2016 Apr 26;67(16):1969-70
27408940 - Rev Port Cardiol. 2016 Mar;35(3):197-8
27102516 - J Am Coll Cardiol. 2016 Apr 26;67(16):1970-1
27102514 - J Am Coll Cardiol. 2016 Apr 26;67(16):1968-9
27102518 - J Am Coll Cardiol. 2016 Apr 26;67(16):1972-3
26718670 - J Am Coll Cardiol. 2015 Dec 29;66(25):2839-41
Otto (10.1016/j.jacc.2015.10.001_bib1) 1997; 95
Brown (10.1016/j.jacc.2015.10.001_bib21) 2008; 135
Kang (10.1016/j.jacc.2015.10.001_bib8) 2010; 121
Baumgartner (10.1016/j.jacc.2015.10.001_bib14) 2009; 22
Smith (10.1016/j.jacc.2015.10.001_bib12) 2011; 364
Austin (10.1016/j.jacc.2015.10.001_bib17) 2009; 28
Marechaux (10.1016/j.jacc.2015.10.001_bib19) 2010; 31
Nishimura (10.1016/j.jacc.2015.10.001_bib6) 2014; 63
Kappetein (10.1016/j.jacc.2015.10.001_bib16) 2012; 60
Brennan (10.1016/j.jacc.2015.10.001_bib5) 2012; 126
Rosenhek (10.1016/j.jacc.2015.10.001_bib9) 2010; 121
Pellikka (10.1016/j.jacc.2015.10.001_bib7) 1990; 15
Vahanian (10.1016/j.jacc.2015.10.001_bib18) 2012; 33
Bergler-Klein (10.1016/j.jacc.2015.10.001_bib20) 2004; 109
Rosenhek (10.1016/j.jacc.2015.10.001_bib2) 2000; 343
Pai (10.1016/j.jacc.2015.10.001_bib13) 2006; 82
Brown (10.1016/j.jacc.2015.10.001_bib4) 2009; 137
Leon (10.1016/j.jacc.2015.10.001_bib15) 2011; 57
Pellikka (10.1016/j.jacc.2015.10.001_bib3) 2005; 111
Leon (10.1016/j.jacc.2015.10.001_bib11) 2010; 363
Martinsson (10.1016/j.jacc.2015.10.001_bib10) 2015; 131
References_xml – volume: 121
  start-page: 151
  year: 2010
  end-page: 156
  ident: bib9
  article-title: Natural history of very severe aortic stenosis
  publication-title: Circulation
  contributor:
    fullname: Schemper
– volume: 121
  start-page: 1502
  year: 2010
  end-page: 1509
  ident: bib8
  article-title: Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis
  publication-title: Circulation
  contributor:
    fullname: Rim
– volume: 137
  start-page: 82
  year: 2009
  end-page: 90
  ident: bib4
  article-title: Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Gammie
– volume: 109
  start-page: 2302
  year: 2004
  end-page: 2308
  ident: bib20
  article-title: Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis
  publication-title: Circulation
  contributor:
    fullname: Heger
– volume: 135
  start-page: 308
  year: 2008
  end-page: 315
  ident: bib21
  article-title: The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis
  publication-title: J Thorac Cardiovasc Surg
  contributor:
    fullname: Schaff
– volume: 364
  start-page: 2187
  year: 2011
  end-page: 2198
  ident: bib12
  article-title: Transcatheter versus surgical aortic-valve replacement in high-risk patients
  publication-title: N Engl J Med
  contributor:
    fullname: Mack
– volume: 95
  start-page: 2262
  year: 1997
  end-page: 2270
  ident: bib1
  article-title: Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome
  publication-title: Circulation
  contributor:
    fullname: Legget
– volume: 111
  start-page: 3290
  year: 2005
  end-page: 3295
  ident: bib3
  article-title: Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up
  publication-title: Circulation
  contributor:
    fullname: Nishimura
– volume: 131
  start-page: 988
  year: 2015
  end-page: 994
  ident: bib10
  article-title: Temporal trends in the incidence and prognosis of aortic stenosis: a nationwide study of the Swedish population
  publication-title: Circulation
  contributor:
    fullname: Sundquist
– volume: 22
  start-page: 1
  year: 2009
  end-page: 23
  ident: bib14
  article-title: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice
  publication-title: J Am Soc Echocardiogr
  contributor:
    fullname: Bermejo
– volume: 28
  start-page: 3083
  year: 2009
  end-page: 3107
  ident: bib17
  article-title: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity score–matched samples
  publication-title: Stat Med
  contributor:
    fullname: Austin
– volume: 15
  start-page: 1012
  year: 1990
  end-page: 1017
  ident: bib7
  article-title: The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Tajik
– volume: 60
  start-page: 1438
  year: 2012
  end-page: 1454
  ident: bib16
  article-title: Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Genereux
– volume: 363
  start-page: 1597
  year: 2010
  end-page: 1607
  ident: bib11
  article-title: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery
  publication-title: N Engl J Med
  contributor:
    fullname: Mack
– volume: 343
  start-page: 611
  year: 2000
  end-page: 617
  ident: bib2
  article-title: Predictors of outcome in severe, asymptomatic aortic stenosis
  publication-title: N Engl J Med
  contributor:
    fullname: Porenta
– volume: 82
  start-page: 2116
  year: 2006
  end-page: 2122
  ident: bib13
  article-title: Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement
  publication-title: Ann Thorac Surg
  contributor:
    fullname: Varadarajan
– volume: 57
  start-page: 253
  year: 2011
  end-page: 269
  ident: bib15
  article-title: Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Nikolsky
– volume: 31
  start-page: 1390
  year: 2010
  end-page: 1397
  ident: bib19
  article-title: Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis
  publication-title: Eur Heart J
  contributor:
    fullname: Bellouin
– volume: 126
  start-page: 1621
  year: 2012
  end-page: 1629
  ident: bib5
  article-title: Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007
  publication-title: Circulation
  contributor:
    fullname: Peterson
– volume: 33
  start-page: 2451
  year: 2012
  end-page: 2496
  ident: bib18
  article-title: Guidelines on the management of valvular heart disease (version 2012)
  publication-title: Eur Heart J
  contributor:
    fullname: Andreotti
– volume: 63
  start-page: e57
  year: 2014
  end-page: e185
  ident: bib6
  article-title: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Bonow
– volume: 82
  start-page: 2116
  year: 2006
  ident: 10.1016/j.jacc.2015.10.001_bib13
  article-title: Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2006.07.043
  contributor:
    fullname: Pai
– volume: 60
  start-page: 1438
  year: 2012
  ident: 10.1016/j.jacc.2015.10.001_bib16
  article-title: Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2012.09.001
  contributor:
    fullname: Kappetein
– volume: 31
  start-page: 1390
  year: 2010
  ident: 10.1016/j.jacc.2015.10.001_bib19
  article-title: Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehq076
  contributor:
    fullname: Marechaux
– volume: 111
  start-page: 3290
  year: 2005
  ident: 10.1016/j.jacc.2015.10.001_bib3
  article-title: Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.495903
  contributor:
    fullname: Pellikka
– volume: 363
  start-page: 1597
  year: 2010
  ident: 10.1016/j.jacc.2015.10.001_bib11
  article-title: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1008232
  contributor:
    fullname: Leon
– volume: 15
  start-page: 1012
  year: 1990
  ident: 10.1016/j.jacc.2015.10.001_bib7
  article-title: The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(90)90234-G
  contributor:
    fullname: Pellikka
– volume: 57
  start-page: 253
  year: 2011
  ident: 10.1016/j.jacc.2015.10.001_bib15
  article-title: Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.12.005
  contributor:
    fullname: Leon
– volume: 121
  start-page: 1502
  year: 2010
  ident: 10.1016/j.jacc.2015.10.001_bib8
  article-title: Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.909903
  contributor:
    fullname: Kang
– volume: 63
  start-page: e57
  year: 2014
  ident: 10.1016/j.jacc.2015.10.001_bib6
  article-title: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2014.02.536
  contributor:
    fullname: Nishimura
– volume: 109
  start-page: 2302
  year: 2004
  ident: 10.1016/j.jacc.2015.10.001_bib20
  article-title: Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000126825.50903.18
  contributor:
    fullname: Bergler-Klein
– volume: 33
  start-page: 2451
  year: 2012
  ident: 10.1016/j.jacc.2015.10.001_bib18
  article-title: Guidelines on the management of valvular heart disease (version 2012)
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehs109
  contributor:
    fullname: Vahanian
– volume: 135
  start-page: 308
  year: 2008
  ident: 10.1016/j.jacc.2015.10.001_bib21
  article-title: The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2007.08.058
  contributor:
    fullname: Brown
– volume: 126
  start-page: 1621
  year: 2012
  ident: 10.1016/j.jacc.2015.10.001_bib5
  article-title: Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.112.091371
  contributor:
    fullname: Brennan
– volume: 95
  start-page: 2262
  year: 1997
  ident: 10.1016/j.jacc.2015.10.001_bib1
  article-title: Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome
  publication-title: Circulation
  doi: 10.1161/01.CIR.95.9.2262
  contributor:
    fullname: Otto
– volume: 137
  start-page: 82
  year: 2009
  ident: 10.1016/j.jacc.2015.10.001_bib4
  article-title: Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2008.08.015
  contributor:
    fullname: Brown
– volume: 131
  start-page: 988
  year: 2015
  ident: 10.1016/j.jacc.2015.10.001_bib10
  article-title: Temporal trends in the incidence and prognosis of aortic stenosis: a nationwide study of the Swedish population
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.012906
  contributor:
    fullname: Martinsson
– volume: 28
  start-page: 3083
  year: 2009
  ident: 10.1016/j.jacc.2015.10.001_bib17
  article-title: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity score–matched samples
  publication-title: Stat Med
  doi: 10.1002/sim.3697
  contributor:
    fullname: Austin
– volume: 121
  start-page: 151
  year: 2010
  ident: 10.1016/j.jacc.2015.10.001_bib9
  article-title: Natural history of very severe aortic stenosis
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.894170
  contributor:
    fullname: Rosenhek
– volume: 22
  start-page: 1
  year: 2009
  ident: 10.1016/j.jacc.2015.10.001_bib14
  article-title: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice
  publication-title: J Am Soc Echocardiogr
  doi: 10.1016/j.echo.2008.11.029
  contributor:
    fullname: Baumgartner
– volume: 343
  start-page: 611
  year: 2000
  ident: 10.1016/j.jacc.2015.10.001_bib2
  article-title: Predictors of outcome in severe, asymptomatic aortic stenosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200008313430903
  contributor:
    fullname: Rosenhek
– volume: 364
  start-page: 2187
  year: 2011
  ident: 10.1016/j.jacc.2015.10.001_bib12
  article-title: Transcatheter versus surgical aortic-valve replacement in high-risk patients
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1103510
  contributor:
    fullname: Smith
SSID ssj0006819
Score 2.6335657
Snippet Abstract Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients...
Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic...
Background Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with...
BACKGROUNDCurrent guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 2827
SubjectTerms Aged
Aged, 80 and over
aortic valve replacement
Aortic Valve Stenosis - diagnosis
Aortic Valve Stenosis - therapy
Cardiology
Cardiovascular
Clinical outcomes
Echocardiography
Female
Follow-Up Studies
Heart attacks
Heart Valve Prosthesis Implantation - standards
Hospitalization
Humans
Internal Medicine
Male
Mortality
Practice Guidelines as Topic
Propensity Score
propensity-matched
Registries
registry
risk
Risk Factors
Severity of Illness Index
Time Factors
Treatment Outcome
watchful waiting
Watchful Waiting - standards
Title Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0735109715067893
https://dx.doi.org/10.1016/j.jacc.2015.10.001
https://www.ncbi.nlm.nih.gov/pubmed/26477634
https://www.proquest.com/docview/1753448671
https://search.proquest.com/docview/1753008241
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkFAviEdpt8DKlXpDYeMk9ibHBYF4lAppC-zNSpyJGiSyq022Ui_97czksQgheiCnJJ7IyXgyD3vmM8D3mNxasjro-FmknEBa5ZBRQCdDisNisn9hwlMD1z_1-W1wOVGTFTjpamE4rbLV_Y1Or7V1e2fQcnMwy_PBmIRT8fopY-QNyeySHvbplIv4JsdLbazDenMPJnaYui2caXK8HmLLMIZSHdUZXvIt4_SW81kbobNN2Gi9RzFqXnALVrDYhvXrdn18B9ILzgUiivFiXqs0wfNhi1LwvpzN9OsfFB0iLZYiL8RNg6xaivu8-i1G5d_HWTWtgVzFGEnQUYym8_qqYmDxvPwEt2env07OnXYfBceSOqscCql0aId0oCtDnVGEFUWeTdzERcwSpTHTiZSZIh65rg1TS14NuRJxGiB6XurvwmoxLfALCIphfc2AM8pSJJaFoQ4wTVIdBfSwlW4PDjsGmlkDl2G6PLIHw-w2zG6-R-zuwbDjsekKQUl1Ydn-R6WRpvSMa16NdQ_U8skX4mLIEvy3x_1uKM1zJxSyBYw8SM3fls30m_HaSVzgdNHQsLsUEM3nRgSWH-hxMa_2g6_vfKk9-MhXnCTjRfuwWs0XeECuTpX04cPRP9mHtdHx3dWPfi3ZT5sl-8E
link.rule.ids 314,780,784,3506,4502,27569,27924,27925,45585,45663,45874
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB6xIO1yWcG-KHRZI3FDoUlqu8mxqhaVRxFSQXCzEmcigrRp1aRIXPjtO5NHEVqxB3JLPJad8Xge9vgzwGFEbi1ZHXT6aagc6VnlkFFAJ0WKwyKyf0HMSwOTSz2-kWd36m4NRu1ZGE6rbHR_rdMrbd186TXc7M2zrDcl4VS8f8oYeQMyux9gQyryfkmoj59f8jx0UN3uwdQOkzcnZ-okr4fIMo6hp46rFC_vLev0lvdZWaGTLfjcuI9iWPdwG9Yw_wIfJ80G-VdITjkZiCimy0Wl0wQviC0LwRdz1uuvjyhaSFosRJaLqxpatRC3WXkvhsXTn3k5q5BcxRRJ0lEMZ4vqrWRk8az4Bjcnv69HY6e5SMGxpM9Kh2IqHdgBPeh6gU4pxApD38Zu7CKmsdKY6tjzUkU8cl0bJJbcGvIlokQi-n7S_w7r-SzHHRAUxPY1I84oS6FYGgRaYhInOpRU2XpuB45aBpp5jZdh2kSyB8PsNsxu_kbs7sCg5bFpT4KS7sKimUiF8UzhG9f8M9gdUKuar-TFkCn4b4vddijNSyMUs0mGHqTig1UxzTPePIlynC1rGvaXJNH8qEVg9YM-n-bVfbn7zk79gk_j68mFuTi9PN-DTS7hjBk_7MJ6uVjiT_J7yni_kuu_fG_8TA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Initial+Surgical+Versus+Conservative+Strategies+in+Patients+With+Asymptomatic+Severe+Aortic+Stenosis&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Taniguchi%2C+Tomohiko%2C+MD&rft.au=Morimoto%2C+Takeshi%2C+MD%2C+MPH&rft.au=Shiomi%2C+Hiroki%2C+MD&rft.au=Ando%2C+Kenji%2C+MD&rft.date=2015-12-29&rft.issn=0735-1097&rft.volume=66&rft.issue=25&rft.spage=2827&rft.epage=2838&rft_id=info:doi/10.1016%2Fj.jacc.2015.10.001&rft.externalDBID=ECK1-s2.0-S0735109715067893&rft.externalDocID=1_s2_0_S0735109715067893
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109714X01014%2Fcov150h.gif